Join us for a Special Meetup: Managing the Emotions of MBC at a Young Age - Jan 29, 2025 at 1pm ET Register here.
Join our Webinar: REAL Talk: Healthy Body and Mind After Breast Cancer Treatment - Jan 23, 2025 at 4pm ET Register here.

Enhertu Way More Effective Than Kadcyla as 2nd Tx for HER2+ MBC

Enhertu Dramatically More Effective Than Kadcyla as Second Treatment for Metastatic HER2-Positive Breast Cancer
September 22, 2021

Enhertu more than doubled the 12-month progression-free survival rate than Kadcyla in people diagnosed with metastatic HER2-positive breast cancer that had been previously treated. Read more...